Research ArticleHIV

CD4+ T cell–mediated HLA class II cross-restriction in HIV controllers

See allHide authors and affiliations

Science Immunology  08 Jun 2018:
Vol. 3, Issue 24, eaat0687
DOI: 10.1126/sciimmunol.aat0687

Article Information

vol. 3 no. 24

Published By: 
  • Received January 21, 2018
  • Accepted April 18, 2018

Author Information

  1. Moran Galperin1,*,
  2. Carine Farenc2,*,
  3. Madhura Mukhopadhyay1,
  4. Dhilshan Jayasinghe2,
  5. Amandine Decroos1,
  6. Daniela Benati1,,
  7. Li Lynn Tan2,,
  8. Lisa Ciacchi2,
  9. Hugh H. Reid2,3,
  10. Jamie Rossjohn2,3,4,§,
  11. Lisa A. Chakrabarti1,5,§, and
  12. Stephanie Gras2,3,§
  1. 1Pasteur Institute, Viral Pathogenesis Unit, Paris, France.
  2. 2Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
  3. 3ARC Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia.
  4. 4Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
  5. 5INSERM, U1108, Paris, France.
  1. Corresponding author. Email: jamie.rossjohn{at} (J.R.); chakra{at} (L.A.C.); stephanie.gras{at} (S.G.)
  1. * These authors contributed equally to this work as co-first authors.

  2. § These authors contributed equally to this work as co-senior authors.

  • Present address: Center for Regenerative Medicine “Stefano Ferrari,” Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.

  • Present address: Research School of Chemistry, Australian National University, Canberra, Australian Capital Territory, Australia.

  • Present address: Pasteur Institute, Virus and Immunity Unit, Paris, France.


Article usage

Article usage: June 2018 to January 2019

Jun 2018757121461799
Jul 201810407095
Aug 20183315022
Sep 20182774427
Oct 20183584435
Nov 20182343217
Dec 20182773115
Jan 20191623218